Close Menu

NEW YORK (GenomeWeb) – Biocept said in a regulatory filing today that it has amended a previous prospectus filed in November with the US Securities and Exchange Commission to now offer about 3.6 million shares of its common stock as well as warrants to purchase another 3.6 million shares at an assumed combined price of $2.11 per share and related warrant.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers uncovered the HIV virus within a tissue sample collected in 1966, the Atlantic reports.

Nature News reports there are a handful of clinical trials underway to evaluate vaginal microbiome seeding of newborns born via caesarian section.

The Washington Post writes that humans may have contributed to the extinction of cave bears some 20,000 years ago.

In PLOS this week: gene variant may protect against trypanosomiasis, GLIS3 role in type 2 diabetes, and more.